United Therapeutics (UTHR) Tops Q1 EPS by 41c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $497.59 --0%
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $2.55, $0.41 better than the analyst estimate of $2.14. Revenue for the quarter came in at $327.6 million versus the consensus estimate of $353.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- KB Home (KBH) Tops Q3 EPS by 16c
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
